These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 18558590)
1. Graves ophthalmopathy: continuing quest in search of initiating factors and new therapies. Fatourechi V Endocr Pract; 2008; 14(4):412-4. PubMed ID: 18558590 [No Abstract] [Full Text] [Related]
2. Use of methotrexate to treat isolated Graves ophthalmopathy developing years after thyroidectomy and iodine 131 treatment of papillary thyroid cancer. Sanyal P; Bing-You RG; Braverman LE Endocr Pract; 2008; 14(4):422-5. PubMed ID: 18558593 [TBL] [Abstract][Full Text] [Related]
7. The use of radioiodine in the treatment of exophthalmic goiter. HAINES SF; KEATING FR J Clin Endocrinol Metab; 1948 Oct; 8(10):813-25. PubMed ID: 18890103 [No Abstract] [Full Text] [Related]
8. Graves' Disease. Smith TJ; Hegedüs L N Engl J Med; 2016 Oct; 375(16):1552-1565. PubMed ID: 27797318 [No Abstract] [Full Text] [Related]
9. Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Antonelli A; Fallahi P; Elia G; Ragusa F; Paparo SR; Ruffilli I; Patrizio A; Gonnella D; Giusti C; Virili C; Centanni M; Shoenfeld Y; Ferrari SM Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101388. PubMed ID: 32059832 [TBL] [Abstract][Full Text] [Related]
12. [Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy]. Wu ZY; Song GX Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):769-71. PubMed ID: 16191339 [TBL] [Abstract][Full Text] [Related]
13. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy. Bartalena L J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983 [TBL] [Abstract][Full Text] [Related]
14. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
15. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging]. Hiromatsu Y; Eguchi H; Tani J Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064 [TBL] [Abstract][Full Text] [Related]
16. Asymmetric ophthalmopathy in a hypothyroid patient. Taylor T; Czarnowski C Can Fam Physician; 2007 Apr; 53(4):635, 637-8. PubMed ID: 17872712 [No Abstract] [Full Text] [Related]
17. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter. Munigoti S; Samat A; Keston Jones M Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082 [No Abstract] [Full Text] [Related]
18. Management of patients with thyroid eye disease. Karra E; Yousseif A; Rose GE; Baldeweg SE Br J Hosp Med (Lond); 2016 Jan; 77(1):C6-9. PubMed ID: 26903468 [No Abstract] [Full Text] [Related]
19. Thyroid Orbitopathy. Wang Y; Tooley AA; Mehta VJ; Garrity JA; Harrison AR; Mettu P Int Ophthalmol Clin; 2018; 58(2):137-179. PubMed ID: 29517649 [No Abstract] [Full Text] [Related]
20. [The stepwise establishment of standardized treatment for the thyroid eye disease]. Qian J Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):404-407. PubMed ID: 28606260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]